Chevy Chase Trust Holdings LLC Lowers Stake in DaVita Inc. $DVA

Chevy Chase Trust Holdings LLC lessened its position in shares of DaVita Inc. (NYSE:DVA) by 4.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,559 shares of the company’s stock after selling 1,142 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in DaVita were worth $3,356,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. National Pension Service lifted its stake in shares of DaVita by 74.3% during the first quarter. National Pension Service now owns 197 shares of the company’s stock worth $30,000 after purchasing an additional 84 shares in the last quarter. Y.D. More Investments Ltd acquired a new position in shares of DaVita during the first quarter worth about $35,000. Ameritas Advisory Services LLC acquired a new position in shares of DaVita during the second quarter worth about $47,000. NewEdge Advisors LLC lifted its stake in shares of DaVita by 20.8% during the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after purchasing an additional 88 shares in the last quarter. Finally, University of Texas Texas AM Investment Management Co. acquired a new position in shares of DaVita during the first quarter worth about $83,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

DVA has been the topic of a number of recent research reports. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a research note on Wednesday, October 8th. Barclays reduced their price objective on DaVita from $160.00 to $149.00 and set an “equal weight” rating on the stock in a research note on Thursday, October 9th. Bank of America reduced their price objective on DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a research note on Wednesday, September 10th. Truist Financial set a $140.00 price target on DaVita in a research note on Tuesday, October 14th. Finally, Wall Street Zen cut DaVita from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Four analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, DaVita has an average rating of “Reduce” and a consensus price target of $153.25.

Insiders Place Their Bets

In related news, insider James O. Hearty sold 2,351 shares of the business’s stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company’s stock, valued at $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by corporate insiders.

DaVita Stock Up 1.8%

Shares of DaVita stock opened at $128.10 on Tuesday. The firm has a market cap of $9.16 billion, a P/E ratio of 12.60, a P/E/G ratio of 0.90 and a beta of 1.13. DaVita Inc. has a fifty-two week low of $122.93 and a fifty-two week high of $179.60. The business has a 50-day moving average price of $132.46 and a 200 day moving average price of $138.05.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. The firm had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.DaVita’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.